"Drug Eruptions" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Adverse cutaneous reactions caused by ingestion, parenteral use, or local application of a drug. These may assume various morphologic patterns and produce various types of lesions.
| Descriptor ID |
D003875
|
| MeSH Number(s) |
C17.800.174.600 C20.543.206.380 C25.100.468.380
|
| Concept/Terms |
Drug Eruptions- Drug Eruptions
- Drug Eruption
- Eruption, Drug
- Eruptions, Drug
- Dermatitis Medicamentosa
- Dermatitis, Adverse Drug Reaction
Morbilliform Drug Reaction- Morbilliform Drug Reaction
- Drug Reaction, Morbilliform
- Drug Reactions, Morbilliform
- Morbilliform Drug Reactions
- Reaction, Morbilliform Drug
- Reactions, Morbilliform Drug
- Maculopapular Exanthem
- Exanthem, Maculopapular
- Exanthems, Maculopapular
- Maculopapular Exanthems
- Morbilliform Exanthem
- Exanthem, Morbilliform
- Exanthems, Morbilliform
- Morbilliform Exanthems
- Maculopapular Drug Eruption
- Drug Eruption, Maculopapular
- Drug Eruptions, Maculopapular
- Eruption, Maculopapular Drug
- Eruptions, Maculopapular Drug
- Maculopapular Drug Eruptions
|
Below are MeSH descriptors whose meaning is more general than "Drug Eruptions".
Below are MeSH descriptors whose meaning is more specific than "Drug Eruptions".
This graph shows the total number of publications written about "Drug Eruptions" by people in this website by year, and whether "Drug Eruptions" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 1 | 0 | 1 |
| 2003 | 1 | 1 | 2 |
| 2006 | 1 | 2 | 3 |
| 2007 | 2 | 1 | 3 |
| 2009 | 2 | 0 | 2 |
| 2010 | 1 | 0 | 1 |
| 2014 | 0 | 1 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 1 | 1 | 2 |
| 2019 | 1 | 1 | 2 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Drug Eruptions" by people in Profiles.
-
Anderson HJ, Lee JB. A Review of Fixed Drug Eruption with a Special Focus on Generalized Bullous Fixed Drug Eruption. Medicina (Kaunas). 2021 Sep 01; 57(9).
-
Zarrabi K, Gemmill JAL, Safaee M, Baer L. Managing dermatologic changes of targeted cancer therapy. J Fam Pract. 2019 Jul/Aug; 68(6):334-340.
-
Kambhampati S, Bauer KE, Bracci PM, Keenan BP, Behr SC, Gordan JD, Kelley RK. Nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh class B cirrhosis: Safety and clinical outcomes in a retrospective case series. Cancer. 2019 09 15; 125(18):3234-3241.
-
Shroff RT, Yarchoan M, O'Connor A, Gallagher D, Zahurak ML, Rosner G, Ohaji C, Sartorius-Mergenthaler S, Subbiah V, Zinner R, Azad NS. The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma. Br J Cancer. 2017 May 23; 116(11):1402-1407.
-
Penn EH, Chung HJ, Keller M. Imatinib mesylate-induced lichenoid drug eruption. Cutis. 2017 Mar; 99(3):189-192.
-
Handley N, Unger A. Antibiotic Overuse and Paronychia: A Teachable Moment. JAMA Intern Med. 2016 Jan; 176(1):19-20.
-
Worden F, Fassnacht M, Shi Y, Hadjieva T, Bonichon F, Gao M, Fugazzola L, Ando Y, Hasegawa Y, Park DJ, Shong YK, Smit JW, Chung J, Kappeler C, Meinhardt G, Schlumberger M, Brose MS. Safety and tolerability of sorafenib in patients with radioiodine-refractory thyroid cancer. Endocr Relat Cancer. 2015 12; 22(6):877-87.
-
Gorcey L, Lewin JM, Trufant J, Meehan SA, McLellan BN. Papular eruption associated with palifermin. J Am Acad Dermatol. 2014 Sep; 71(3):e101-2.
-
Lacouture ME, Mitchell EP, Piperdi B, Pillai MV, Shearer H, Iannotti N, Xu F, Yassine M. Skin toxicity evaluation protocol with panitumumab (STEPP), a phase II, open-label, randomized trial evaluating the impact of a pre-Emptive Skin treatment regimen on skin toxicities and quality of life in patients with metastatic colorectal cancer. J Clin Oncol. 2010 Mar 10; 28(8):1351-7.
-
Bremmer M, Deng A, Gaspari AA. A mechanism-based classification of dermatologic reactions to biologic agents used in the treatment of cutaneous disease: Part 1. Dermatitis. 2009 Jul-Aug; 20(4):182-92.